Serina Therapeutics, Inc. (SER): Gross Profit
Older than the company's other figures. The latest Gross Profit is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$102.0K
Year ended 2023-12-31
-32.7%
3-year compound annual growth
-37.1%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $102.0K | +385.7% | 2024-03-22, From 2023-01-01 |
| 2022-12-31 | $21.0K | -83.2% | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | $125.0K | -62.7% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $335.0K | -77.4% | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | $1.48M | +43.8% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $1.03M | -16.5% | 2020-03-31, From 2018-01-01 |
| 2017-12-31 | $1.24M | n/a | 2019-04-01, From 2017-01-01 |